Deletion of ALD518

Comment: and merge into research activities of the company Alder Biopharmaceuticals, as WhatamIdoing suggests. Drugs in trials are not (yet) proven fully effective & safe, certainly are not in any meaningful way in widespread use, and definitely have yet to establish any real world notability in gaining even a significant minority usage against existing treatment approaches (as it were they are 'trivial minority view'). They may be notable in the current work of a company and show the research direction that is being undertaken, and so possibly/probably should be (briefly) mentioned in a pharmaceutical company article. As Nerdseeksblonde & Axl point out, fluffy |peacocking links are not proof of notability and so this and most other drugs in trial-stages generally should not exist IMHO (obvious case-by-case consideration rather than absolute blanket ban
Stance: delete
Cited policy: Wikipedia:Manual of Style (WP:PEACOCK)

Comment: reasonably well-written stub. Meets , and notability alone is a terrible reason to delete an otherwise decent article
Stance: keep
Cited policy: Wikipedia:Verifiability (WP:V)

Comment: per 
Stance: keep
Cited policy: Wikipedia:The Heymann Standard (WP:HEY)

Comment: Wikipedia can present information on this subject without forcing the investigational therapeutic into its own article.  The company is http://www.alderbio.com/18/IN%20THE%20NEWS/ probably notable; their three individual products are probably |not yet notable.  The three products, however, would probably make a nice and very  section in an article about the business
Stance: merge
Cited policy: Wikipedia:What Wikipedia is not (WP:CRYSTAL||WP:DUE)

Comment: I don't regard phase II trials (or even phase III or IV trials) as evidence of notability. The references provided are not |reliable medical sources. I couldn't find any reliable sources to add
Stance: delete
Cited policy: Wikipedia:Reliable sources (WP:MEDRS)